Publicacións (32) Publicacións nas que participase algún/ha investigador/a

2008

  1. A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: A GEICO (Grupo Español de Investigación en Cáncer de Ovario) trial

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 31, Núm. 5, pp. 481-487

  2. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

    Current Medical Research and Opinion, Vol. 24, Núm. 10, pp. 2931-2942

  3. An independent algorithm to check the monitor units calculation in radiosurgery

    Medical Physics, Vol. 35, Núm. 1, pp. 48-51

  4. Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer

    Journal of the National Cancer Institute, Vol. 100, Núm. 6, pp. 421-427

  5. CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC)

    Lung Cancer, Vol. 61, Núm. 2, pp. 209-213

  6. Conservative management of patients with early endometrial carcinoma: A systematic review

    Clinical and Translational Oncology, Vol. 10, Núm. 3, pp. 155-162

  7. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation

    Radiotherapy and Oncology, Vol. 88, Núm. 3, pp. 342-350

  8. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy

    Brachytherapy, Vol. 7, Núm. 4, pp. 310-315

  9. Hormonal therapy in breast cancer

    Revista de medicina de la Universidad de Navarra, Vol. 52, Núm. 1, pp. 40-48

  10. Indications for adjuvant radiotherapy treatment after surgery and novel modalities for treatment

    Gynecologic Oncology, Vol. 110, Núm. 3 SUPPL.2

  11. Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells

    Gene Therapy, Vol. 15, Núm. 7, pp. 473-483

  12. Investigación mediante técnicas de dosimetría biológica, de posibles efectos sobre la salud por causa de lasradiaciones ionizantes en profesionales de líneas aéreas: estudio poblacional

    Prevención: Revista técnica de seguridad y salud laborales, Núm. 183, pp. 18-35

  13. Lights and shadows of the tumoral marker CA-125 in ovarian cancer

    Clinical and Translational Oncology, Vol. 10, Núm. 8, pp. 449-452

  14. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors

    Cancer, Vol. 112, Núm. 7, pp. 1538-1546

  15. Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies

    Trends in Pharmacological Sciences, Vol. 29, Núm. 8, pp. 383-390

  16. Neoangiogenesis in early cervical cancer: Correlation between color Doppler findings and risk factors. A prospective observational study

    World Journal of Surgical Oncology, Vol. 6

  17. Novel chemotherapy approaches in chemoradiation protocols

    Gynecologic Oncology, Vol. 110, Núm. 3 SUPPL.2

  18. Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma

    Clinical and Translational Oncology, Vol. 10, Núm. 6, pp. 372-374

  19. Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755

  20. Polly Matzinger's "danger model" finds its predicted danger-denoting self moieties

    Inmunologia, Vol. 27, Núm. 4, pp. 205-211